Galectin Therapeutics (GALT) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.40% |
| Dec 31, 2025 | 11.64% |
| Sep 30, 2025 | -55.60% |
| Jun 30, 2025 | -43.58% |
| Mar 31, 2025 | -63.20% |
| Dec 31, 2024 | -37.96% |
| Sep 30, 2024 | 30.72% |
| Jun 30, 2024 | 37.72% |
| Mar 31, 2024 | 28.01% |
| Dec 31, 2023 | 32.49% |
| Sep 30, 2023 | 23.72% |
| Jun 30, 2023 | -22.43% |
| Mar 31, 2023 | -39.83% |
| Dec 31, 2022 | -49.11% |
| Sep 30, 2022 | -52.90% |
| Jun 30, 2022 | -22.51% |
| Mar 31, 2022 | 46.81% |
| Dec 31, 2021 | 41.31% |
| Sep 30, 2021 | 11.72% |
| Jun 30, 2021 | -19.15% |
| Mar 31, 2021 | -48.09% |
| Dec 31, 2020 | -38.93% |
| Sep 30, 2020 | -32.92% |
| Jun 30, 2020 | -22.06% |
| Mar 31, 2020 | 463.36% |
| Dec 31, 2019 | 438.16% |
| Sep 30, 2019 | 378.15% |
| Jun 30, 2019 | 372.90% |
| Mar 31, 2019 | 58.79% |
| Dec 31, 2018 | 116.44% |
| Sep 30, 2018 | 51.42% |
| Jun 30, 2018 | 20.16% |
| Mar 31, 2018 | -64.77% |
| Dec 31, 2017 | -73.66% |
| Sep 30, 2017 | -56.49% |
| Jun 30, 2017 | -48.87% |
| Mar 31, 2017 | -38.58% |
| Dec 31, 2016 | -40.19% |
| Sep 30, 2016 | -25.09% |
| Jun 30, 2016 | -31.61% |
| Mar 31, 2016 | -23.97% |
| Dec 31, 2015 | -11.02% |
| Sep 30, 2015 | -31.31% |
| Jun 30, 2015 | -22.88% |
| Mar 31, 2015 | -18.77% |
| Dec 31, 2014 | 177.02% |
| Sep 30, 2014 | 220.33% |
| Jun 30, 2014 | 562.09% |
| Mar 31, 2014 | 412.77% |
| Dec 31, 2013 | 12.05% |
| Sep 30, 2013 | -12.65% |
| Jun 30, 2013 | -60.78% |
| Mar 31, 2013 | -53.69% |
| Dec 31, 2012 | 44.60% |
| Sep 30, 2012 | 38.13% |
| Jun 30, 2012 | 63.26% |
| Dec 31, 2011 | 4.95% |